Natco Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Natco Pharma Quarterly Results    (NTPH)

Here are the latest quarterly results of Natco Pharma. For more details, see the Natco Pharma financial fact sheet and Natco Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Natco Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m4,2675,6227,6785,3865,4355,5674,5574,923 
Other income Rs m55114201359400233310210 
Turnover Rs m4,3225,7367,8795,7455,8355,8004,8675,133 
Expenses Rs m3,0482,7573,8453,2103,2303,4833,0743,010 
Gross profit Rs m1,2192,8653,8332,1762,2052,0841,4831,913 
Depreciation Rs m160172180184202207217220 
Interest Rs m4243302850635265 
Profit before tax Rs m1,0722,7643,8242,3232,3532,0471,5241,838 
Tax Rs m228590827512537454320410 
Profit after tax Rs m8442,1742,9971,8111,8161,5931,2041,428 
Gross profit margin %28.651.049.940.440.637.432.538.9 
Effective tax rate %21.321.321.622.022.822.221.022.3 
Net profit margin %19.838.739.033.633.428.626.429.0 
Diluted EPS Rs 5.1 13.1 18.0 10.9 10.9 9.6 7.2 8.6  
Diluted EPS (TTM) Rs 33.1 34.4 41.8 47.1 53.0 49.5 38.7 36.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Natco Pharma 1QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   SHASUN PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare NATCO PHARMA With:   SHASUN PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare NATCO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Views on news

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

How We Made 14.64% Trading Profit in Just 2 Days

Dec 12, 2019

A high probability trade that worked to perfection for my subscribers.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets? (The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Dec 13, 2019 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NATCO PHARMA

NATCO PHARMA - ACTAVIS COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS